TY - JOUR
T1 - Age less than two years is not a risk factor for mortality after mitral valve replacement in children
AU - Rafii, Daniela Y.
AU - Davies, Ryan R
AU - Carroll, Sheila J.
AU - Quaegebeur, Jan M.
AU - Chen, Jonathan M.
PY - 2011/4
Y1 - 2011/4
N2 - Background Outcomes for mitral valve replacement (MVR) in the pediatric population are generally reported as poor, particularly in patients less than 2 years old. We compared long-term morbidity and mortality associated with MVR between patients less than 2 years old and patients 2 to 18 years old. Methods We evaluated pediatric patients undergoing MVR from March 1990 to November 2007 at our institution. Morbidity and mortality was compared between patients less than 2 years and patients 2 to 18 years old. Primary endpoints measured were postoperative survival, long-term survival, reoperation, cerebrovascular accident or transient ischemic attack, and significant bleeding events. Results Forty-five patients underwent 54 MVRs. Median age was 3.1 years; 18 patients were under 2 years. Median follow-up time was 5.4 years. There was no statistically significant difference between long-term or short-term survival between the two age groups, with 30-day survival of 89% (younger patients) versus 100% (older patients), and 10-year survival of 82% (younger patients) versus 85% (older patients). Freedom from reoperation for the younger age group was 40% at 10 years versus 96% for the older patients, p = 0.003. Conclusions In our population, there was no statistically significant difference in survival between patients less than 2 years and patients 2 to 18 years. In children undergoing MVR, age less than 2 years remains a risk factor for reoperation but not for mortality.
AB - Background Outcomes for mitral valve replacement (MVR) in the pediatric population are generally reported as poor, particularly in patients less than 2 years old. We compared long-term morbidity and mortality associated with MVR between patients less than 2 years old and patients 2 to 18 years old. Methods We evaluated pediatric patients undergoing MVR from March 1990 to November 2007 at our institution. Morbidity and mortality was compared between patients less than 2 years and patients 2 to 18 years old. Primary endpoints measured were postoperative survival, long-term survival, reoperation, cerebrovascular accident or transient ischemic attack, and significant bleeding events. Results Forty-five patients underwent 54 MVRs. Median age was 3.1 years; 18 patients were under 2 years. Median follow-up time was 5.4 years. There was no statistically significant difference between long-term or short-term survival between the two age groups, with 30-day survival of 89% (younger patients) versus 100% (older patients), and 10-year survival of 82% (younger patients) versus 85% (older patients). Freedom from reoperation for the younger age group was 40% at 10 years versus 96% for the older patients, p = 0.003. Conclusions In our population, there was no statistically significant difference in survival between patients less than 2 years and patients 2 to 18 years. In children undergoing MVR, age less than 2 years remains a risk factor for reoperation but not for mortality.
UR - http://www.scopus.com/inward/record.url?scp=79953091420&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953091420&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2010.11.058
DO - 10.1016/j.athoracsur.2010.11.058
M3 - Article
C2 - 21440150
AN - SCOPUS:79953091420
SN - 0003-4975
VL - 91
SP - 1228
EP - 1234
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 4
ER -